Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Number of holders
-
2,949
-
Total 13F shares, excl. options
-
1,221,220,466
-
Shares change
-
+1,679,517
-
Total reported value, excl. options
-
$164,097,646,774
-
Value change
-
+$170,284,213
-
Put/Call ratio
-
78%
-
Number of buys
-
1,395
-
Number of sells
-
-1,283
-
Price
-
$134.21
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q3 2022
3,174 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q3 2022.
AbbVie Inc. - Common Stock (ABBV) has 2,949 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,221,220,466 shares
of 1,767,364,935 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (156,022,414 shares), BlackRock Inc. (132,960,149 shares), STATE STREET CORP (77,486,317 shares), JPMORGAN CHASE & CO (58,479,009 shares), Capital International Investors (45,827,258 shares), Capital Research Global Investors (36,193,102 shares), GEODE CAPITAL MANAGEMENT, LLC (33,830,501 shares), MORGAN STANLEY (26,786,473 shares), PRICE T ROWE ASSOCIATES INC /MD/ (24,516,628 shares), and NORTHERN TRUST CORP (21,854,796 shares).
This table shows the top 2,949 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.